Barnett AH
Semaglutide is also approved for weight management in people battling obesity, especially those with a Body Mass Index (BMI) of 30 or greater, or a BMI of 27 or above when paired with weight-related conditions such as high cholesterol, type 2 diabetes, or hypertension
According to the Patient Information Leaflet, Wegovy should appear as a clear and colourless solution
Soliman NA, Abdel Ghafar MT, AbuoHashish NA, Ibrahim MA, Eid AM, El-Gohary RM, Abo El Gheit RE, Elshamy AM (2023) The possible role of naringenin in the prevention of alcohol-induced neurochemical and neurobehavioral deficits
Tirzepatide activates two (GLP-1 and GIP)